NCT01157897View on ClinicalTrials.gov

Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
MalariaPlasmodium Vivax
Interventions
BIOLOGICAL

VMP001

Plasmodium vivax malaria protein 001 (VMP001) with GSK Biologicals' Adjuvant System AS01B

OTHER

P. vivax sporozoite challenge

P. vivax sporozoite challenge

Trial Locations (1)

20910

Clinical Trials Center, Walter Reed Army Institute of Reserach, Silver Spring

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

The PATH Malaria Vaccine Initiative (MVI)

OTHER

collaborator

Walter Reed Army Institute of Research (WRAIR)

FED

collaborator

United States Department of Defense

FED

collaborator

GlaxoSmithKline

INDUSTRY

lead

U.S. Army Medical Research and Development Command

FED